The study will be conducted in a prospective randomised controlled. Patients will be allocated into three groups
Control group:
The patient will receive fentanyl patch 50 microgram
TPVB group:
The patient will receive thoracic vertebral plane lock 0.4ml/kg bupivacaine 0.1 25% will be administered. For continuous infusion catheter will be inserted . Then a rate of 7ml / hour to max 10 ml / hour of bupivacaine 0.0625%
SAPB group,:
Patient will receive serratus anterior plane block 0.4ml / kg bupivacaine 0.125% will be injected to open the space then a catheter will be advanced For continuous infusion of 0.0625 % bupivacaine at 7 ml / hour
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
ASA 1\_3 Age 18\_60 Unilateral fracture ribs
You may not be if
Drug allergy Morbid obese Opioid dependence Patients refuse